Medtronic (MDT) Reports Q3 EPS of $1.04

Go back to Medtronic (MDT) Reports Q3 EPS of $1.04

Medtronic (MDT) PT Raised to $90 at Jefferies on 'Very Good' Q3

February 18, 2015 7:51 AM EST

Jefferies analyst Raj Denhoy reiterated a Buy rating and boosted his price target on Medtronic, Inc. (NYSE: MDT) to $89.00 (from $83.00) following Q3 results.

Denhoy commented, "MDT posted a very good F3Q, highlighted by: strength in CRDM, where the US quadpole... More

Medtronic (MDT) PT Lifted to $90 at Piper Jaffray Post Q3

February 18, 2015 7:44 AM EST

Piper Jaffray analyst Brooks West reiterated an Overweight rating and boosted his price target on Medtronic, Inc. (NYSE: MDT) to $90.00 (from $83.00) following Q3 results.

West commented, "Medtronic reported F3Q15 results, the last before reporting as combined Medtronic/ Covidien, with revenues of $4.318B (+8%cc) easily beating... More